ACADIA PHARMACEUTICALS INC. (ACAD) Gross profit 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) annual gross profit history from SEC filings — each fiscal year as reported.
$982.5MFY2025 · since FY2016: $14.3M → $982.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $982.5M | +12.2% |
| FY2024 | $876.0M | +27.9% |
| FY2023 | $684.8M | +35.1% |
| FY2022 | $507.1M | +7.1% |
| FY2021 | $473.3M | +9.7% |
| FY2020 | $431.5M | +31.7% |
| FY2019 | $327.7M | +55.0% |
| FY2018 | $211.4M | +82.5% |
| FY2017 | $115.8M | +712.7% |
| FY2016 | $14.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice